Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: Windtree Therapeutics Inc /De/ quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
Windtree Therapeutics Inc /De/ Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $185M, a 12.3% decline year-over-year.

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$185M	-$26M	-12.3%	Dec 31, 2023	10-K	2024-04-16
Q4 2022	$211M	-$1.85M	-0.87%	Dec 31, 2022	10-K	2024-04-16
Q4 2021	$213M	+$5.26M	+2.53%	Dec 31, 2021	10-K	2023-03-31
Q4 2020	$208M	+$6.09M	+3.02%	Dec 31, 2020	10-K	2022-03-31
Q4 2019	$202M	+$5.8M	+2.96%	Dec 31, 2019	10-K	2021-03-29
Q4 2018	$196M	+$6.55M	+3.46%	Dec 31, 2018	10-K	2020-04-03
Q4 2017	$189M	-$64.1M	-25.3%	Dec 31, 2017	10-K/A	2019-04-23
Q4 2016	$253M	+$17.6M	+7.48%	Dec 31, 2016	10-K	2018-04-17
Q4 2015	$236M	+$22.9M	+10.8%	Dec 31, 2015	10-K	2017-03-31
Q4 2014	$213M	+$18.5M	+9.5%	Dec 31, 2014	10-K/A	2016-03-29
Q4 2013	$194M	+$16.7M	+9.37%	Dec 31, 2013	10-K	2015-03-16
Q4 2012	$178M	+$13.1M	+7.96%	Dec 31, 2012	10-K	2014-03-17
Q4 2011	$165M			Dec 31, 2011	10-K	2013-03-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.